
Sign up to save your podcasts
Or


On this episode of Stock Movers:
- GSK raised its profit and sales forecasts for the year, aided by its HIV and immunology medicines, in Emma Walmsley’s last report as CEO.
- Mercedes-Benz Group confirmed its annual outlook and plans to proceed with a €2 billion share buyback after the company’s margin climbed in 3Q.
- Equinor said 3Q earnings slumped as oil prices softened and trading profits declined, its adjusted operating income after tax fell by about a quarter to $1.51 billion, missing the average analyst estimate.
See omnystudio.com/listener for privacy information.
By iHeartPodcasts4.6
1919 ratings
On this episode of Stock Movers:
- GSK raised its profit and sales forecasts for the year, aided by its HIV and immunology medicines, in Emma Walmsley’s last report as CEO.
- Mercedes-Benz Group confirmed its annual outlook and plans to proceed with a €2 billion share buyback after the company’s margin climbed in 3Q.
- Equinor said 3Q earnings slumped as oil prices softened and trading profits declined, its adjusted operating income after tax fell by about a quarter to $1.51 billion, missing the average analyst estimate.
See omnystudio.com/listener for privacy information.

405 Listeners

1,168 Listeners

2,202 Listeners

1,968 Listeners

420 Listeners

1,038 Listeners

1,303 Listeners

62 Listeners

59 Listeners

154 Listeners

85 Listeners

80 Listeners

76 Listeners

8 Listeners

11 Listeners